Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This class of medications sounds pretty new because the excitement surrounding the drugs (and celeb interest) has exploded in recent years, but GLP-1s have been around for 20 years
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease
The substance sold here is supplied as a research-grade reference compound for in-vitro use only
REFERENCES: Ganguly, P
US$ 29.87
US$ 29.44
US$ 27.82
US$ 23.92
US$ 21.48
US$ 29.96
